We're currently fundraising! Become an early investor in Bioverge to own an expanding portfolio of leading TechBio startups through a single investment 🔬! Learn more and invest today 💸!

Press

Ifimhgcnro2ahat1ibzg
Press

Episode 18: Investing in Startup Companies with Neil Littman

Neil Littman is the CEO and Founder of Bioverge Inc. Bioverge is an investment platform that funds visionary entrepreneurs with the aim of transforming healthcare and bringing science fiction to life. In this episode of MedStreet Journal, Neil Littman shares what he’s working on in Bioverge, his experiences in the healthcare industry and how it led him towards creating a company with an entrepreneurial management team skilled in venture creation as well as science.

Continue Reading >
Vjron1fzt5iau7km3omf
Press

Episode #146: Neil Littman, Bioverge, “The More Risk You Kill, Inherently, The More Value You Create”

Podcast link: https://mebfaber.com/2019/03/13/episode-146-neil-littman-the-more-risk-you-kill-inherently-the-more-value-you-create/ Neil Littman is the Founder of Bioverge, a highly curated impact investment platform exclusively dedicated to healthcare. Bioverge enables a motivated public to finance and support the health-related causes and companies most important to them. Previously, Neil was a member of the Executive Leadership Team and Director ...

Continue Reading >
Dcmovofdrmux7l1zn8qe
Press

Neil Littman of Bioverge: 5 Things I Need To See Before Making A VC Investment

As part of our series about “5 Things I Need To See Before Making A VC Investment”, I had the pleasure of interviewing Neil J. Littman, MS. He has comprehensive healthcare-specific financial experience in venture capital, business development, and investment banking. As a member of the Executive Leadership Team and ...

Continue Reading >
58i54cveruav1pdir5ne
Press

Will new equity crowdfunding rules boost health care startups? One S.F. firm is betting on it.

Even as venture capital last year poured $28.5 billion into biotech companies globally and biotech IPOs raised more than $5 billion in the first quarter of this year alone, Neil Littman says he saw both a disturbing trend, as well as a potential opportunity. Investors focused more capital into larger ...

Continue Reading >
Obols5votkmhh1nfaocj
Press

Managed marketplaces and reality TV: How a new generation of gatekeepers is opening biotech up to amateur investors

Starton Therapeutics, a drug delivery biotech, is raising its next round of capital through Unicorn Hunters, a streaming show that invites viewers to consider and invest in a variety of startups alongside a panel of celebrity investors.

Continue Reading >
T3jw61mvsy6ey99mx10x
Health + Tech, Investing, Press

Investment Opportunity, You Can Now Invest In Bioverge!

The Bioverge Reg CF Offering is Officially Live 🎊 and Accepting Investments!

Continue Reading >